X
09Oct

Caremark Round II: Beware Red Flags in Drug Development

Goodwin | | Return|
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/caremark-round-ii-beware-red-flags-in-18599/

Related

Soft Tissue Massage Considered First-Aid For OSHA Recordkeeping Purposes

Most employers with more than 10 employees are required to keep a record of serious work-related inj...

Read More >

The Ohio Bureau Of Workers’ Compensation Has A New Rule For The Payment Of Medical Treatment For Concussion Related Injuries

On January 1, 2020, a new Ohio Administrative Code Rule became effective with respect to payment for...

Read More >

One more thing from the Connecticut General Assembly: School Construction Bill Passes During a “Special Session”

As you are aware from these pages, Connecticut’s General Assembly produced a plethora of bills affe...

Read More >

Can an Employee be Fired for being Gay or Transgender?

HR Professionals will soon know the answer to this question. The United States Supreme Court is pr...

Read More >

BIA to Establish Procedures for Federally Recognizing Alaskan Tribes

On January 2, 2020, the Bureau of Indian Affairs (BIA) issued a proposed rule to create a new 25 Cod...

Read More >

HSR Thresholds Will Decrease for 2021 Transactions

Size-of-transaction threshold under Hart-Scott-Rodino Act will decrease to $92 million; the first th...

Read More >